DTV 50 is contraindicated in patients: with previous hypersensitivity reaction to dolutegravir; receiving dofetilide due to the potential for increased dofetilide plasma concentrations and the risk for serious and/or life-threatening events.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education